IKZF1 and plasma cell myeloma: Whereas thalidomide and close analogues can bind rodent cereblon [18, 19], degradation of rodent transcription factors, such as Ikaros and Aiolos, does not occur, and murine multiple myeloma cells are insensitive to IMID treatment [57].